http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100947209-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2007-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100947209-B1 |
| titleOfInvention | Anticancer sensitizer containing chlorogenic acid |
| abstract | The present invention relates to an anticancer sensitizer comprising chlorogenic acid or a derivative thereof, and more particularly, to an anticancer sensitizer comprising chlorogenic acid or a derivative thereof which increases the effect of an anticancer agent when treating cancer by administering an anticancer agent. In addition, the present invention is a method for overcoming anticancer drug resistance by administering a composition for inhibiting anticancer drug resistance comprising chlorogenic acid or a derivative thereof and a pharmaceutically acceptable carrier, an anticancer composition comprising an anticancer agent in addition to the composition and the anticancer sensitizer. It is about.n n n n Anticancer sensitizer, chlorogenic acid, anticancer drug resistance |
| priorityDate | 2007-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.